Twist Bioscience Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 919

Employees

  • Stock Symbol
  • TWST

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $38.36
  • (As of Wednesday Closing)

Twist Bioscience General Information

Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 681 Gateway Boulevard
  • South San Francisco, CA 94080
  • United States
+1 (408) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Twist Bioscience Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$38.36 $39.51 $11.46 - $43.21 $2.22B 57.8M 1.25M -$3.61

Twist Bioscience Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 30-Sep-2023 FY 2022 30-Sep-2022 FY 2021 30-Sep-2021
EV 1,883,512 898,733 1,537,255 4,817,120
Revenue 262,364 245,109 203,565 132,333
EBITDA (187,858) (188,516) (214,742) (144,346)
Net Income (205,802) (204,618) (217,863) (152,098)
Total Assets 732,815 776,403 961,378 702,097
Total Debt 91,878 94,069 94,912 62,921
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Twist Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.

Request a free trial

Twist Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Twist Bioscience‘s full profile, request access.

Request a free trial

Twist Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize t
Drug Discovery
South San Francisco, CA
919 As of 2023
00000
00000000 00000

000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000000000000
Menlo Park, CA
000 As of 0000
00000
000000000 00000

00000

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000000000000
Cherry Hill, NJ
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Twist Bioscience Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacific Biosciences Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
Vyant Bio Formerly VC-backed Cherry Hill, NJ 00 000.00 000000000 000.00
Deep Genomics Venture Capital-Backed Toronto, Canada 000 00000 00000000000 00000
CustomArray Corporate Backed or Acquired Redmond, WA 00 000000&0
Just - Evotec Biologics Formerly VC-backed Seattle, WA 00 0000 000000&0 0000
You’re viewing 5 of 26 competitors. Get the full list »

Twist Bioscience Patents

Twist Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230407290-A1 Methylation-mediated adapter removal on nucleic acid sequences Pending 07-Mar-2022 00000000000
US-20230340461-A1 Combinatorial dna assembly for multispecific antibodies Pending 14-Feb-2022 00000000000
US-20230257448-A1 Bispecific sars-cov-2 antibodies and methods of use Pending 03-Jan-2022 00000000000 0
US-20230323449-A1 Compositions and methods for detection of variants Pending 17-Dec-2021 0000000000
US-20230175062-A1 Nanoelectric devices and use thereof Pending 08-Dec-2021 C12Q1/6874
To view Twist Bioscience’s complete patent history, request access »

Twist Bioscience Executive Team (25)

Name Title Board Seat Contact Info
Emily Leproust Ph.D Co-Founder, Chief Executive Officer & Chairman
Patrick Finn Ph.D Chief Operating Officer, Operations & President
Adam Laponis Chief Financial Officer, Finance
Siyuan Chen Ph.D Chief Technology Officer
Robert Werner Chief Accounting Officer, Accounting
You’re viewing 5 of 25 executive team members. Get the full list »

Twist Bioscience Board Members (19)

Name Representing Role Since
Emily Leproust Ph.D Twist Bioscience Co-Founder, Chief Executive Officer & Chairman 000 0000
Jan Johannessen iGlobe Partners Board Member 000 0000
Keith Crandell ARCH Venture Partners Board Member 000 0000
Melissa Starovasnik Self Board Member 000 0000
Minqi Li Twist Bioscience Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Twist Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Twist Bioscience Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Camena Bioscience 03-Jul-2023 00000 0000 000.00 Biotechnology
Revelar Biotherapeutics 09-May-2022 0000 00000 000 Drug Discovery 00000 000
Abveris 01-Dec-2021 0000000000 00000 Drug Discovery 00000 000
Revelar Biotherapeutics 01-Nov-2021 000000000 000.00 Drug Discovery 00000 000
iGenomX 14-Jun-2021 Merger/Acquisition 000.00 Other Healthcare Technology Systems 00000 000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Twist Bioscience Subsidiaries (1)

Company Name Industry Location Founded
Abveris Drug Discovery Quincy, MA 0000
To view Twist Bioscience’s complete subsidiaries history, request access »

Twist Bioscience ESG

Risk Overview

Risk Rating

Updated July, 06, 2023

25.79 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,605

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 870

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 386

Rank

00.00

Percentile

To view Twist Bioscience’s complete esg history, request access »

Twist Bioscience Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Revelar Biotherapeutics 09-May-2022 0000 00000 000 Completed
  • 2 buyers
Revelar Biotherapeutics 01-Nov-2021 Corporate 000.00 Completed
To view Twist Bioscience’s complete exits history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »